| Marina Gerber, MD | |
|
1 Malcolm Ave, Teterboro, NJ 07608-1011 | |
| (201) 393-5357 | |
| (201) 462-4712 |
| Full Name | Marina Gerber |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1 Malcolm Ave, Teterboro, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003063082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 25MA04946200 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marina Gerber, MD 17 Glimpsewood Ln, Morristown, NJ 07960-3767 Ph: (973) 285-1621 | Marina Gerber, MD 1 Malcolm Ave, Teterboro, NJ 07608-1011 Ph: (201) 393-5357 |
News Archive
Nearly two out of three patients have one or more precipitating factors that may contribute to hospital admissions nationwide for heart failure, according to a new UCLA study. Pneumonia, irregular heart beats, and obstructed blood flow to the heart are the most frequent factors.
In the first comprehensive report into age related stress and health at work to be carried out in Britain researchers from the Institute of Work, Health and Organisations also found that the effects of stress in our working lives can stay with us well into retirement.
In work reported in the Nov. 24 online edition of the Proceedings of the National Academy of Sciences (PNAS) , Elly Nedivi, associate professor of neurobiology at the Picower Institute for Learning and Memory, and colleagues found that a type of neuron implicated in autism spectrum disorders remodels itself in a strip of brain tissue only as thick as four sheets of tissue paper at the upper border of cortical layer 2.
Glenmark Pharmaceuticals today announced that its Novel Chemical Entity "Revamilast" (GRC 4039) has initiated Phase IIb human dose range finding trials globally. Revamilast is an orally active, potent and selective inhibitor of phosphodiesterase 4 (PDE 4) that is currently being developed by Glenmark for the treatment of chronic inflammatory disorders such as Asthma, Rheumatoid Arthritis (RA) and other inflammatory diseases.
Patient Advocate Foundation - a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases - today released their annual Patient Data Analysis Report, which documents the scope and complexity of the healthcare finance, access and job retention issues routinely confronted by patients at the national and state-specific level.
› Verified 3 days ago
Leza N Gallo, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Quest Diagnostics, 1 Malcolm Avenue, Teterboro, NJ 07608 Phone: 201-393-5035 | |
Dr. Uma Ayer, M.D Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07606 Phone: 203-393-5606 | |
William Ellsworth Tarr Jr., M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Quest Diagnostics Inc, Teterboro, NJ 07608 Phone: 201-393-5752 | |
Xinzhu Pang, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Quest Diagnostics, One Malcolm Ave, Teterboro, NJ 07068 Phone: 201-893-5632 | |
Dr. Ronald David Luff, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-6007 Fax: 201-462-4772 | |
Ecaterina F Tamas, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-6317 |